Hickman 导管在临床前猪模型中用于长期血管通路
March 31st, 2023
描述了一种可靠且可重复的方法，用于插入和维护隧道式 Hickman 导管，用于猪的长期血管通路。放置中心静脉导管可以方便地每天从清醒的动物身上取样全血，并静脉注射药物和液体。
该协议描述了一种可靠且可重复的技术，用于在大型动物模型中插入和维护用于长期血管通路的隧道Hickman导管。该方法允许方便地每天从清醒的动物身上取样全血，并静脉注射药物和液体。大型动物长期中心静脉管路面临的一些主要挑战是感染和损伤。
由于大型动物偶尔能够接触到线路并造成机械创伤。为了缓解这些挑战，我们团队发明了我们的特殊袋子，可以保护管路，同时仍然可以轻松访问同一根导管。中心静脉导管是大型动物研究中的宝贵设备，因为它们促进了广泛的医疗应用，但对其插入和维护的最佳实践尚未达成共识。
作为回应，我们提出了一种方案，该方案全面描述了一种在猪中正确放置隧道式希克曼导管的方法，该方法可最大限度地减少与导管相关的并发症和发病率。在100多头猪中使用我们的方法已经实现了长期通畅和最小的并发症发生率。该协议提供了一种优化希克曼导管寿命的方法，以及在其使用过程中处理问题的指南。
View the full transcript and gain access to thousands of scientific videos
概述
本协议描述了一种可靠且可重复的技术，用于在猪体内插入和维护隧道化Hickman导管，以实现长期血管通路。这种方法便于每天从清醒的动物体内取全血样本，以及静脉注射药物和液体。
关键研究组成部分
科学领域
- 兽医学
- 大型动物研究
- 生物医学工程
背景
- 中心静脉导管对大型动物研究中的各种医学应用至关重要。
- 挑战包括由于动物接触导管而导致的感染和机械性创伤。
- 已开发出特殊的导管保护套，可以在保护导管的同时方便接触。
- 目前尚未就导管插入和维护的最佳实践达成共识。
研究目的
- 提出在猪体内置入隧道化Hickman导管的全面协议。
- 最大限度地减少与导管相关的并发症和发病率。
- 提高大型动物模型中长期血管通路的可靠性。
使用的方法
- 在猪体内插入隧道化Hickman导管。
- 使用保护套以减轻风险。
- 每日血液采样和静脉注射技术。
- 在研究期间监测并发症。
主要结果
- 成功地放置导管，并降低了并发症。
- 实现了有效的每日采样和药物管理。
- 保护策略显著减少了机械性创伤。
- 协议显示出可重复性和可靠性。
结论
- 提出的协议增强了猪体内长期血管通路的安全性和有效性。
- 创新的保护措施可以降低与导管使用相关的风险。
- 这种技术可以应用于各种大型动物研究环境。
常见问题解答
Executive Industry Relevance
Reliable long-term vascular access in preclinical swine models is critical for translational studies requiring repeated blood sampling and intravenous dosing. The described Hickman catheter protocol addresses a key operational challenge by minimizing line-related complications, supporting uninterrupted data collection and study continuity. This capability enhances predictive confidence in large animal studies, directly impacting the quality of preclinical pharmacology and safety data.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables sustained access for serial biomarker sampling in disease-relevant large animal models.
- Supports longitudinal pharmacokinetic and pharmacodynamic studies with reduced procedural variability.
- Facilitates mechanistic de-risking by ensuring consistent sample integrity over extended study periods.
Screening & Assay Development
- Provides a validated vascular access platform for standardized compound administration and sampling.
- Improves reproducibility of in vivo assays by minimizing catheter-related interruptions.
- Enables scalable study designs by reducing line failure rates and associated downtime.
Translational & Preclinical Research
- Aligns with translational biomarker strategies by supporting high-frequency, low-stress sampling regimens.
- Maintains continuity from early discovery through preclinical validation by reducing animal morbidity and data loss.
- Decreases risk of confounding variables related to vascular access, strengthening preclinical evidence packages.
Pipeline & Workflow Integration
This protocol integrates into the preclinical workflow from early discovery through lead optimization, supporting both exploratory and regulatory-enabling studies in large animal models.
- Discovery Biology: Ensures reliable access for hypothesis-driven sampling and intervention studies.
- Screening: Standardizes compound delivery and sample collection for robust in vivo assay outputs.
- Analytics: Enables quantitative, longitudinal measurement of blood-based endpoints with minimal sample loss.
- Translational Research: Supports biomarker continuity and data integrity across study phases.
- Enterprise Reuse: Establishes a reproducible vascular access method adaptable to diverse large animal protocols.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces biological variability in preclinical studies.
- Operational Value: Enhances standardization, reproducibility, and scalability of large animal workflows.
- Strategic Value: Supports efficient go/no-go decisions by minimizing study delays and data gaps.
- Portfolio Impact: Enables risk-adjusted advancement by ensuring high-quality, uninterrupted data streams.
Implementation Considerations
- Requires surgical expertise in large animal vascular access and catheter placement.
- Needs appropriate instrumentation for catheter insertion, maintenance, and monitoring.
- Demands cross-team adherence to standardized maintenance and troubleshooting protocols.
- Adaptable to various swine models but may require protocol adjustments for other species.
- Potential limitations include the need for specialized protective devices and ongoing line surveillance.
